[摘要] 目的 探究磷酸西格列汀联合二甲双胍治疗初发2型糖尿病的临床疗效。方法 将2017年6月—2018年月6月该院内分泌科收治的116例初发2型糖尿病患者纳入研究对象范畴，均分为对照组及观察组;对照组患者实行常规治疗，观察组患者实行磷酸西格列汀及二甲双胍联合治疗，对比2组患者的血糖指标及不良反应发生率。 结果 ②经对比治疗结果可知，对照组与观察组治疗前后空腹血糖及餐后2 h血糖各项指标相比间差异较为明显，2组数据差异有统计学意义(P<0.05)。①经对比治疗结果发现，对照组与观察组不良反应发生率分别为15.52%及1.72%相比间差异较为明显，2组数据差异有统计学意义(P<0.05)。结论 初发2型糖尿病实行磷酸西格列汀及二甲双胍联合治疗的效果明显，值得在临床治疗领域中使用推广。

    [关键词] 磷酸西格列汀;二甲双胍;初发2型糖尿病

    [中图分类号] R587.1 [文献标识码] A [文章编号] 1672-4062(2019)05(b)-0052-02

    [Abstract] Objective To explore the clinical efficacy of Sigliptin phosphate combined with metformin in the treatment of newly diagnosed type 2 diabetes mellitus. Methods A total of 116 cases of newly diagnosed type 2 diabetes mellitus admitted to the department of endocrinology of our hospital from June 2017 to June 2018 were divided into control group and observation group. Patients in control group were given routine treatment ......